The DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Effect of Aspirin on Vascular and Nonvascular Outcomes: Meta-analysis of Randomized Controlled Trials
Open accessAbstract
BACKGROUND: The net benefit of aspirin in prevention of CVD and nonvascular events remains unclear. Our objective was to assess the impact (and safety) of aspirin on vascular and nonvascular outcomes in primary prevention. DATA SOURCES: MEDLINE, Cochrane Library of Clinical Trials (up to June 2011) and unpublished trial data from investigators. STUDY SELECTION: Nine randomized placebo-controlled trials with at least 1000 participants each, reporting on cardiovascular disease (CVD), nonvascular outcomes, or death were included. DATA EXTRACTION: Three authors abstracted data. Study-specific odds ratios (ORs) were combined using random-effects meta-analysis. Risks vs benefits were evaluated by comparing CVD risk reductions with increases in bleeding. RESULTS: During a mean (SD) follow-up of 6.0 (2.1) years involving over 100, 000 participants, aspirin treatment reduced total CVD events by 10% (OR, 0.90; 95% CI, 0.85-0.96; number needed to treat, 120), driven primarily by reduction in nonfatal MI (OR, 0.80; 95% CI, 0.67-0.96; number needed to treat, 162). There was no significant reduction in CVD death (OR, 0.99; 95% CI, 0.85-1.15) or cancer mortality (OR, 0.93; 95% CI, 0.84-1.03), and there was increased risk of nontrivial bleeding events (OR, 1.31; 95% CI, 1.14-1.50; number needed to harm, 73). Significant heterogeneity was observed for coronary heart disease and bleeding outcomes, which could not be accounted for by major demographic or participant characteristics. CONCLUSIONS: Despite important reductions in nonfatal MI, aspirin prophylaxis in people without prior CVD does not lead to reductions in either cardiovascular death or cancer mortality. Because the benefits are further offset by clinically important bleeding events, routine use of aspirin for primary prevention is not warranted and treatment decisions need to be considered on a case-by-case basis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Quantifying heterogeneity in a meta‐analysis
Higgins, J. P. T., & Thompson, S. G. (2002) · Statistics in Medicine · doi:10.1002/sim.1186 · Cited by 36,763
Hansson, L., Zanchetti, A., Carruthers, S. G., Dahlöf, B., Elmfeldt, D., Julius, S., Ménard, J., Rahn, K. H., Wedel, H., & Westerling, S. (1998) · The Lancet · doi:10.1016/s0140-6736(98)04311-6 · Cited by 5,728
Mehran, R., Rao, S. V., Bhatt, D. L., Gibson, C. M., Caixeta, A., Eikelboom, J., Kaul, S., Wiviott, S. D., Menon, V., Nikolsky, E., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.009449 · Cited by 4,476
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309023291001 · Cited by 4,055
Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients
Pirmohamed, M., James, S., Meakin, S., Green, C., Scott, A. K., Walley, T. J., Farrar, K., Park, B. K., & Breckenridge, A. M. (2004) · BMJ · doi:10.1136/bmj.329.7456.15 · Cited by 3,230
Clopidogrel and Aspirin versus Aspirin Alone for the Prevention of Atherothrombotic Events
Bhatt, D. L., Fox, K. A. A., Hacke, W., Berger, P. B., Black, H. R., Boden, W. E., Cacoub, P., Cohen, E. A., Creager, M. A., Easton, J. D., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060989 · Cited by 2,837
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Journal of Clinical Epidemiology · doi:10.1016/s0895-4356(98)00131-0 · Cited by 2,379
Chesebro, J. H., Knatterud, G., Roberts, R., Borer, J., Cohen, L. S., Dalen, J., Dodge, H. T., Francis, C. K., Hillis, D., & Ludbrook, P. (1987) · Circulation · doi:10.1161/01.cir.76.1.142 · Cited by 2,244
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M., Gordon, D., Gaziano, J. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050613 · Cited by 1,945
Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Circulation · doi:10.1161/01.cir.0000020190.45892.75 · Cited by 1,854
A strategy to reduce cardiovascular disease by more than 80%
Wald, N. J., & Law, M. R. (2003) · BMJ · doi:10.1136/bmj.326.7404.1419 · Cited by 1,568
Rothwell, P. M., Fowkes, F. G. R., Belch, J. F., Ogawa, H., Warlow, C. P., & Meade, T. W. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62110-1 · Cited by 1,497
Rothwell, P. M., Wilson, M., Elwin, C.-E., Norrving, B., Algra, A., Warlow, C. P., & Meade, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61543-7 · Cited by 1,351
Prepared by: British Cardiac Society, B. H. S. (2005) · Heart · doi:10.1136/hrt.2005.079988 · Cited by 1,216
Randomised trial of prophylactic daily aspirin in British male doctors
Peto, R., Gray, R., Collins, R., Wheatley, K., Hennekens, C., Jamrozik, K., Warlow, C., Hafner, B., Thompson, E., Norton, S., et al. (1988) · BMJ · doi:10.1136/bmj.296.6618.313 · Cited by 1,166
Roncaglioni, M. C. (2001) · The Lancet · doi:10.1016/s0140-6736(00)03539-x · Cited by 999
Belch, J., MacCuish, A., Campbell, I., Cobbe, S., Taylor, R., Prescott, R., Lee, R., Bancroft, J., MacEwan, S., Shepherd, J., et al. (2008) · BMJ · doi:10.1136/bmj.a1840 · Cited by 977
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Berger, J. S., Roncaglioni, M. C., Avanzini, F., Pangrazzi, I., Tognoni, G., & Brown, D. L. (2006) · JAMA · doi:10.1001/jama.295.3.306 · Cited by 789
Fowkes, F. G. R. (2010) · JAMA · doi:10.1001/jama.2010.221 · Cited by 624
U.S. Preventive Services Task Force* (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00008 · Cited by 533
Kassoff, A. (1992) · JAMA · doi:10.1001/jama.1992.03490100090033 · Cited by 481
De Berardis, G., Sacco, M., Strippoli, G. F. M., Pellegrini, F., Graziano, G., Tognoni, G., & Nicolucci, A. (2009) · BMJ · doi:10.1136/bmj.b4531 · Cited by 395
Serebruany, V. L., Steinhubl, S. R., Berger, P. B., Malinin, A. I., Baggish, J. S., Bhatt, D. L., & Topol, E. J. (2005) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2005.01.049 · Cited by 344
Wolff, T., Miller, T., & Ko, S. (2009) · Annals of Internal Medicine · doi:10.7326/0003-4819-150-6-200903170-00009 · Cited by 263
Pignone, M., Alberts, M. J., Colwell, J. A., Cushman, M., Inzucchi, S. E., Mukherjee, D., Rosenson, R. S., Williams, C. D., Wilson, P. W., & Kirkman, M. S. (2010) · Circulation · doi:10.1161/cir.0b013e3181e3b133 · Cited by 223
Meta-Analysis of Multiple Primary Prevention Trials of Cardiovascular Events Using Aspirin
Bartolucci, A. A., Tendera, M., & Howard, G. (2011) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2011.02.325 · Cited by 186
Effect of Aspirin on Mortality in the Primary Prevention of Cardiovascular Disease
Raju, N., Sobieraj-Teague, M., Hirsh, J., O'Donnell, M., & Eikelboom, J. (2011) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.01.018 · Cited by 169
De Berardis, G., Sacco, M., Evangelista, V., Filippi, A., Giorda, C. B., Tognoni, G., Valentini, U., Nicolucci, A., & ACCEPT-D Study Group (2007) · Trials · doi:10.1186/1745-6215-8-21 · Cited by 161
Ajani, U. A., Ford, E. S., Greenland, K. J., Giles, W. H., & Mokdad, A. H. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2005.08.042 · Cited by 158
Aspirin for primary prevention of cardiovascular events in patients with diabetes: A meta-analysis
Zhang, C., Sun, A., Zhang, P., Wu, C., Zhang, S., Fu, M., Wang, K., Zou, Y., & Ge, J. (2010) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2009.09.029 · Cited by 150
Verhagen, A. P., de Vet, H. C. W., de Bie, R. A., Kessels, A. G. H., Boers, M., Bouter, L. M., & Knipschild, P. G. (1998) · Digital Academic REpository of VU University Amsterdam (Vrije Universiteit Amsterdam) · Cited by 146
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
Ridker, P. M., Cook, N. R., Lee, I.-M. M., Gordon, D., Gaziano, J. M., Manson, J. A. E., Hennekens, C. H., & Buring, J. E. (2005) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000172386.83719.df · Cited by 128
A strategy to reduce cardiovascular disease by more than 80%
British Medical Journal Publishing Group (2003) · BMJ · doi:10.1136/bmj.327.7415.586-b · Cited by 109
Pearson, T. A., Blair, S. N., Daniels, S. R., Eckel, R. H., Fair, J. M., Fortmann, S. P., Franklin, B. A., Goldstein, L. B., Greenland, P., Grundy, S. M., et al. (2002) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · Cited by 97
Zalewska, J. (2009) · PubMed · Cited by 95
Dose Effects of Aspirin on Gastric Prostaglandins and Stomach Mucosal Injury
Lee, M., Cryer, B., & Feldman, M. (1994) · Annals of Internal Medicine · doi:10.7326/0003-4819-120-3-199402010-00002 · Cited by 79
Aspirin for everyone older than 50?
Elwood, P. C., Morgan, G., Brown, G., & Pickering, J. E. (2005) · BMJ · doi:10.1136/bmj.330.7505.1440 · Cited by 54
Moneta, G. L. (2011) · Yearbook of Vascular Surgery · doi:10.1016/j.yvas.2011.07.046 · Cited by 50
A Randomized Trial of Low-Dose Aspirin in the Primary Prevention of Cardiovascular Disease in Women
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000165831.51904.01 · Cited by 50
Cook, N. R., Lee, I.-M. M., & Gaziano, J. M. (2005) · ACC Current Journal Review · doi:10.1016/j.accreview.2005.09.031 · Cited by 46
Roizen, M. F. (2007) · Yearbook of Anesthesiology and Pain Management · doi:10.1016/s1073-5437(08)70007-x · Cited by 45
Wilson, P. W. F., Mukherjee, D., Williams, C. D., Rosenson, R. S., Cushman, M., Inzucchi, S. E., Kirkman, M. S., Pignone, M. P., Alberts, M. J., & Colwell, J. A. (2020) · Carolina Digital Repository (University of North Carolina at Chapel Hill) · doi:10.17615/gg65-6e63 · Cited by 44
(2005) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000180822.67328.18 · Cited by 40
Silagy, C., McNeil, J. J., Donnan, G. A., et al. (1994) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1994.tb06864.x · Cited by 17
(2006) · Obstetrics and Gynecology · doi:10.1097/01.aog.0000203663.53514.cd · Cited by 7
Cited by
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · EP Europace · doi:10.1093/europace/eus305 · Cited by 3,822
2012 focused update of the ESC Guidelines for the management of atrial fibrillation
Authors/Task Force Members, Camm, A. J., Lip, G. Y. H., De Caterina, R., Savelieva, I., Atar, D., Hohnloser, S. H., Hindricks, G., Kirchhof, P., ESC Committee for Practice Guidelines (CPG), et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs253 · Cited by 2,899
Rothwell, P. M., Price, J. F., Fowkes, F. G. R., Zanchetti, A., Roncaglioni, M. C., Tognoni, G., Lee, R., Belch, J. F., Wilson, M., Mehta, Z., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(11)61720-0 · Cited by 839
Algra, A. M., & Rothwell, P. M. (2012) · The Lancet Oncology · doi:10.1016/s1470-2045(12)70112-2 · Cited by 831
Adam, M. A., Pura, J., Goffredo, P., Dinan, M. A., Reed, S. D., Scheri, R. P., Hyslop, T., Roman, S. A., & Sosa, J. A. (2015) · Journal of Clinical Oncology · doi:10.1200/jco.2014.59.8391 · Cited by 335
Metadata
- Authors
- Seshasai, S. R. K.
- Venue
- Archives of Internal Medicine
- Publisher
- American Medical Association (AMA)
- Published
- 2012-02-13
- Volume
- 172
- Issue
- 3
- Pages
- 209
- ISSN
- 0003-9926 (ISSN-L)
- OpenAlex
- W2130549133
- Cited by
- 272
- References
- 50
- FWCI
- 30.12
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.